• Cardiovascular

    Stem cell study helps clarify the best time for therapy to aid heart attack survivors

A research network led by a Mayo Clinic physician found that stem cells obtained from bone marrow delivered two to three weeks after a person has a heart attack did not improve heart function. This is the first study to systematically examine the timing and method of stem cell delivery and provides vital information for the field of cell therapy.

The results were presented this morning at the 2011 Scientific Sessions of the American Heart Association Meeting in Orlando, Fla. They also will be published online in The Journal of the American Medical Association to coincide with the presentation.

Click here to view the news release

*NOTE *   Downloadable video for this story is intended for web use only.